Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Sydes

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|February 13, 2008
Parenteral oestrogen in the treatment of prostate cancer: a systematic reviewG Norman, M E Dean, R E Langley, et al.
Trials|October 11, 2023
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidenceE J Mitchell, D Appelbe, A Bravery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 studyG M Mead, M R Sydes, J Walewski, et al.
Contemporary Clinical Trials|June 17, 2021
PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT studyE J Bass, N Klimowska-Nassar, T Sasikaran, et al.
British Journal of Cancer|June 12, 2014
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trialsM E Abdel-Rahman, J Butler, M R Sydes, et al.
Trials|June 20, 2020
Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trialsK D Coulman, A Nicholson, A Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsJ S Whelan, R C Jinks, A McTiernan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2005
Issues in data monitoring and interim analysis of trialsA M Grant, D G Altman, A B Babiker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysisC L Vale, D J Fisher, I R White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|February 13, 2008
Parenteral oestrogen in the treatment of prostate cancer: a systematic reviewG Norman, M E Dean, R E Langley, et al.
Trials|October 11, 2023
e-Consent in UK academic-led clinical trials: current practice, challenges and the need for more evidenceE J Mitchell, D Appelbe, A Bravery, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 studyG M Mead, M R Sydes, J Walewski, et al.
Contemporary Clinical Trials|June 17, 2021
PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT studyE J Bass, N Klimowska-Nassar, T Sasikaran, et al.
British Journal of Cancer|June 12, 2014
No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trialsM E Abdel-Rahman, J Butler, M R Sydes, et al.
Trials|June 20, 2020
Understanding and optimising patient and public involvement in trial oversight: an ethnographic study of eight clinical trialsK D Coulman, A Nicholson, A Shaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2011
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsJ S Whelan, R C Jinks, A McTiernan, et al.
Health Technology Assessment (Winchester, England)|March 15, 2005
Issues in data monitoring and interim analysis of trialsA M Grant, D G Altman, A B Babiker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2018
What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysisC L Vale, D J Fisher, I R White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2025
Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems dataC Jones, P Dutey-Magni, L R Murphy, et al.
Pageof 3